Foresite Capital Opportunity Management V, 10% Owner of Alumis ALMS, has filed 19 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $11.6M. The latest trade was on 04/01.

FV

FV

Foresite Capital Opportunity Management V

10% Owner

Company

Alumis ALMS

First filing

23/01/03

Trades

90 trades

Buys / sales

19 / 0

12-month net buying

$11.6M

Last trade

04/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Eikon TherapeuticsEIKN	Open-market buy	02/04	02/06	55,555 sh	$18.00	$999,990	+4.4%
AlumisALMS	Open-market buy	01/08	01/12	411,764 sh2 trades	$17.00avg.	$6,999,988	+16.5%
AlumisALMS	Open-market buy	25/11/21	25/11/25	72,212 sh	$7.38	$532,924.56	+2.8%
AlumisALMS	Open-market buy	25/11/17–25/11/19	25/11/19	507,874 sh4 trades	$6.09avg.	$3,094,725.06	+25.0%
AlumisALMS	Open-market buy	25/05/02–25/05/06	25/05/06	45,000 sh2 trades	$4.50avg.	$202,300	+1.1%
AlumisALMS	Open-market buy	24/07/01	24/07/03	2,500,000 sh2 trades	$16.00avg.	$40,000,000	+146.8%
TP Theseus Pharmaceuticals	Open-market buy	23/07/17	23/07/19	700,000 sh2 trades	$2.97avg.	$2,079,000	+102.1%
KB Kinnate Biopharma	Open-market buy	23/05/08	23/05/10	1,780,000 sh2 trades	$2.80avg.	$4,984,000	No record
PB Pardes Biosciences	Open-market buy	23/04/05	23/04/06	773,952 sh	$1.50	$1,160,928	+9.7%
TP Theseus Pharmaceuticals	Open-market buy	22/12/29	23/01/03	500,000 sh2 trades	$5.00avg.	$2,500,000	+70.5%